Skip to Main Content

Author Details

Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
1992
83
36
PMIDPaper TitleJournal TitlePublished Year
37056551Atypical Nelson Syndrome Following Right Partial and Left Total Nephrectomy With Incidental Bilateral Total Adrenalectomy of Renal Cell Carcinoma: A Chat Generative Pre-Trained Transformer (ChatGPT)-Assisted Case Report and Literature Review.Cureus2023
37546794Prostate Cancer Reshapes the Secreted and Extracellular Vesicle Urinary Proteomes.bioRxiv2023
35226974Testing of full face snorkel masks to examine recreational snorkeler deaths.Undersea Hyperb Med2022
36061737Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells.ACS Omega2022
32071439Copy number alterations are associated with metastatic-lethal progression in prostate cancer.Prostate Cancer Prostatic Dis2020
35474889A multi-institutional randomized controlled trial comparing first-generation transrectal high-resolution micro-ultrasound with conventional frequency transrectal ultrasound for prostate biopsy.BJUI Compass2020
26902887DNA methylation profiles in African American prostate cancer patients in relation to disease progression.Genomics2019
29956356A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer.Prostate2018
27358489Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.Clin Cancer Res2017
28106542Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.Cancer Biomark2017
28145099Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.Mol Oncol2017
27810448Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.J Urol2017
27350604Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Nat Commun2016
26362343Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.Urol Oncol2016
26327354Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.J Urol2016
27617307PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.Eur Urol Focus2016
27635949Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.Am J Surg Pathol2016
27174589Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.Mod Pathol2016
25819722Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator.Eur Urol2015
26497208Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.Oncotarget2015
26172920Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.PLoS One2015
25901286Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results.J Immunother Cancer2015
25925891A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res2015
25939393A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.Prostate2015
25978559Robotic-Assisted Ureteral Re-implantation: A Case Series.J Laparoendosc Adv Surg Tech A2015
26027762Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.Urol Oncol2015
24200968miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.Cell Cycle2014
24747657Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.J Urol2014
23352372Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer.Urology2013
23775902Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.Proteomics Clin Appl2013
23732709Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling.Oncogenesis2013
23533145In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.Proteomics2013
23515404Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.Clin Cancer Res2013
23232570A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.Adv Anat Pathol2013
22339264Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.J Proteome Res2012
22986220Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.Mol Cell Proteomics2012
23107099NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.Urology2012
21132389Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study.Qual Life Res2011
22188997Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.BMC Clin Pathol2011
21929308Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer.Expert Rev Anticancer Ther2011
21697344Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines.J Gen Virol2011
19839780Renal functional outcomes after cryoablation of small renal masses.J Endourol2010
22112489Molecular pathology of prostate cancer.Cancer Biomark2010
20156376Feasibility of using guidelines to choose treatment for prostate cancer.Can J Urol2010
20151969Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer.BJU Int2010
20334419In-depth proteomic analyses of direct expressed prostatic secretions.J Proteome Res2010
20303100Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer.J Urol2010
19265472Is there correlation of nerve-sparing status and return to baseline urinary function after robot-assisted laparoscopic radical prostatectomy?J Endourol2009
19690195Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue.Clin Cancer Res2009
19603828Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF.J Proteome Res2009
  • 1 - 50 of 83

Recommended Authors

Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 14
Cynthia Kuk
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 3
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 6
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 8
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 20
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 9
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 9
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 12
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 10
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 8
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 7
Neil E Fleshner
University of Toronto
Career Start Year 1989
Number of shared co-authors 28
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 2
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 16
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 1
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 5
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 11
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 10
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 6
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 4
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 6
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 9
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 14
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 10
Eric J Bergstralh
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 1
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 16
Anthony J Costello
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 9
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 6

Collaborators

Dean A Troyer
Eastern Virginia Medical School
Co-authored papers 26
Oliver J Semmes
Eastern Virginia Medical School
Co-authored papers 17
Richard R Drake
Medical University of South Carolina
Co-authored papers 14
Julius O Nyalwidhe
Eastern Virginia Medical School
Co-authored papers 13
Daniel W Lin
Co-authored papers 12
David G McLeod
Co-authored papers 11
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 11
Martin E Gleave
University of British Columbia
Co-authored papers 10
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 10
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 7
Lawrence D True
University of Washington School of Medicine
Co-authored papers 7
Ladan Fazli
University of British Columbia
Co-authored papers 7
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 6
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 5
Yunee Kim
University of Toronto
Co-authored papers 5
Elaine A Ostrander
National Cancer Institute
Co-authored papers 5
Jonathan L Wright
University of Washington Medical Center
Co-authored papers 5
Vladimir Ignatchenko
Margaret Cancer Center
Co-authored papers 5
Suzanne Kolb
Fred Hutchinson Cancer Research Center
Co-authored papers 5
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers 4
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Jeffrey A Medin
Medical College of Wisconsin
Co-authored papers 3
Paul C Boutros
University of California los angeles
Co-authored papers 3
Marina Bibikova
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Co-authored papers 3
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 2
Anthony O Gramolini
University of Toronto, University Avenue
Co-authored papers 2
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 2
Tamara Jamaspishvili
Queen's University
Co-authored papers 2
James Y Dai
Fred Hutchinson Cancer Center
Co-authored papers 2
Jeremy A Squire
University of Sao Paulo
Co-authored papers 2
Release 1.2